{"entity":{"type":"insider","cik":"0001606831","url":"/insider/0001606831","json_url":"/insider/0001606831.json","name":"MACARTNEY LAWSON","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2018-05-31","last":"2024-11-08","span_basis":"filed_date"},"name_variants":[{"name":"MACARTNEY LAWSON","source":"filing","n_filings":5,"first_seen":"2018-05-31","last_seen":"2024-11-08"}],"transactions":[{"id":2311014,"accession":"0000950170-24-124296","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-124296","line_url":"/filing/0000950170-24-124296#line-2","is_derivative":false,"issuer_cik":"0001606831","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001606831","owner_cik":"0001606831","owner_name":"MACARTNEY LAWSON","owner_display_name":"MACARTNEY LAWSON","owner_url":"/insider/0001606831","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":68.6667,"price_display":"68.67","price_state":"stated","total_value":137333.4,"total_display":"137,333.40","total_whole":"137,333","shares_owned_after":47965.0,"shares_owned_after_display":"47,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-08","scope":"insider"},{"id":8545184,"accession":"0001209191-23-030794","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-030794","line_url":"/filing/0001209191-23-030794#line-2","is_derivative":false,"issuer_cik":"0001606831","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001606831","owner_cik":"0001606831","owner_name":"MACARTNEY LAWSON","owner_display_name":"MACARTNEY LAWSON","owner_url":"/insider/0001606831","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":384000.0,"total_display":"384,000.00","total_whole":"384,000","shares_owned_after":47965.0,"shares_owned_after_display":"47,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":8607179,"accession":"0001209191-23-025473","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-025473","line_url":"/filing/0001209191-23-025473#line-2","is_derivative":false,"issuer_cik":"0001606831","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001606831","owner_cik":"0001606831","owner_name":"MACARTNEY LAWSON","owner_display_name":"MACARTNEY LAWSON","owner_url":"/insider/0001606831","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":22.0038,"price_display":"22.00","price_state":"stated","total_value":352060.8,"total_display":"352,060.80","total_whole":"352,061","shares_owned_after":47965.0,"shares_owned_after_display":"47,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-24","filed_date":"2023-04-24","scope":"insider"},{"id":8393486,"accession":"0001209191-23-024725","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-024725","line_url":"/filing/0001209191-23-024725#line-2","is_derivative":false,"issuer_cik":"0001606831","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001606831","owner_cik":"0001606831","owner_name":"MACARTNEY LAWSON","owner_display_name":"MACARTNEY LAWSON","owner_url":"/insider/0001606831","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20786.0,"shares_display":"20,786","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":415720.0,"total_display":"415,720.00","total_whole":"415,720","shares_owned_after":47965.0,"shares_owned_after_display":"47,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-18","scope":"insider"},{"id":6706380,"accession":"0001209191-18-034482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-034482","line_url":"/filing/0001209191-18-034482#line-1","is_derivative":false,"issuer_cik":"0001606831","issuer_name":"Viking Therapeutics, Inc.","issuer_ticker":"VKTX","issuer_name_source":null,"issuer_url":"/issuer/0001606831","owner_cik":"0001606831","owner_name":"MACARTNEY LAWSON","owner_display_name":"MACARTNEY LAWSON","owner_url":"/insider/0001606831","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.00001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47965.0,"shares_display":"47,965","price_per_share":5.219,"price_display":"5.22","price_state":"stated","total_value":250329.335,"total_display":"250,329.34","total_whole":"250,329","shares_owned_after":47965.0,"shares_owned_after_display":"47,965","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-29","filed_date":"2018-05-31","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001607678","name":"Viking Therapeutics, Inc.","url":"/issuer/0001607678","role":"Director","n_filings":5,"first_seen":"2018-05-31","last_seen":"2024-11-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001606831","retrieved_at":"2026-08-25T07:39:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}